Clinical trial • Phase I • Other
ADCX-020 for Locally advanced or metastatic solid tumors | Solid tumor
Phase I trial of ADCX-020 for Locally advanced or metastatic solid tumors | Solid tumor. None/Not specified-controlled. 150 participants.
Overview
- Trial Therapeutic Area
- Other
- Trial Disease
- Locally advanced or metastatic solid tumors | Solid tumor
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 17-11-2025
- First CTIS Authorization Date
- 23-02-2026
Trial design
None/Not specified-controlled Phase I trial across 3 sites in Spain.
- Comparator
- None/Not specified
- Target Sample Size
- 150
Recruitment
- Planned Sample Size
- 150
- Recruitment Window Months
- 45
Geography
- Total Number Of Sites
- 3
- Total Number Of Participants
- 150
Spain
- Earliest CTIS Part Ii Submission Date
- 17-12-2025
- Latest Decision Or Authorization Date
- 23-02-2026
- Processing Time Days
- 68
- Number Of Sites
- 3
- Number Of Participants
- 55
Sites
- Site Name
- Hospital Universitario Hm Sanchinarro
- Department Name
- Oncology
- Contact Person Name
- Emiliano Calvo Aller
- Contact Person Email
- emiliano.calvo@startmadrid.com
- Site Name
- Hospital Hm Nou Delfos
- Department Name
- Oncology
- Contact Person Name
- Tatiana Hernandez Guerrero
- Contact Person Email
- Tatiana.hernandez@start-barcelona.com
- Site Name
- Hospital Universitario Fundacion Jimenez Diaz
- Department Name
- Oncology
- Contact Person Name
- Victor Moreno García
- Contact Person Email
- victor.moreno@startmadrid.com
Sponsor
Primary sponsor
- Full Name
- Adcytherix
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- France
Investigational products
- Investigational Product Name
- ADCX-020
Related trials
Other published trials that may interest you.